• GoodRx Holdings Inc GDRX.OQ GDRX.O is expected to show a rise in quarterly revenue when it reports results on February 27 for the period ending December 31 2024

• The Santa Monica California-based company is expected to report a 1.6% increase in revenue to $199.795 million from $196.64 million a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on November 7 2024, for the period ended December 31, was for revenue of $200.000 million. (SAL is based on Total Revenue basis)

• ​LSEG's mean analyst estimate for GoodRx Holdings Inc is for earnings of 10 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 8 "hold" and 1 "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for GoodRx Holdings Inc is $6.50​, above​ its last closing price of $4.84. ​​​

The company's guidance on November 7 2024 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of of USD68 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated February 25 at 13:48 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)